Semaglutide shows slower but more sustainable resultsstudies show consistent reduction over several months, with long-term maintenance possible through ongoing treatment and support
A large set for trials, mainly published in the past 3 years, have consistently demonstrated that this drug class achieves high levels of weight loss over a the period of duration for which the drugs are taken
But the peptides being injectedwhether approved medications or underground "research chemicals"are synthetic
Results Weighted HbA1c and BMI cohorts included 865 and 642 semaglutide users and 779 and 537 DPP4i users, respectively
Strength training two to three times per week, eating enough protein, staying hydrated, and avoiding long periods of under-fueling all help protect muscle
The most meaningful results are assessed at the one-to-two year mark, not the first few weeks